ASTHMA; EOSINOPHILIC
Clinical trials for ASTHMA; EOSINOPHILIC explained in plain language.
Never miss a new study
Get alerted when new ASTHMA; EOSINOPHILIC trials appear
Sign up with your email to follow new studies for ASTHMA; EOSINOPHILIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Asthma pill trial halted: hope for fewer attacks remains unproven
Disease control TerminatedThis study tested a daily pill called dexpramipexole for people with severe eosinophilic asthma, a type of asthma linked to high levels of certain white blood cells. The goal was to see if the drug could reduce serious asthma attacks over 52 weeks. The trial was terminated early,…
Matched conditions: ASTHMA; EOSINOPHILIC
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 17, 2026 13:45 UTC
-
Asthma drug trial halted: hope for severe cases unfulfilled
Disease control TerminatedThis study tested an oral drug called dexpramipexole in 654 people with severe eosinophilic asthma, a type of asthma linked to high levels of certain white blood cells. The goal was to see if the drug could reduce asthma attacks and improve lung function over 52 weeks. However, t…
Matched conditions: ASTHMA; EOSINOPHILIC
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 17, 2026 13:42 UTC